Key Publications March 4, 2022

Fenofibrate use is associated with lower mortality and fewer cardiovascular events in patients with diabetes: Results of 10,114 patients from the Korean National Health insurance service cohort.

Diabetes Care. 2021;44:1868-1876

Jo SH, Nam H, Lee J, Park S, Lee J, Kyoung DS